Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetic Seizure Therapy (MST) for the Treatment of Severe Mood Disorder

NCT00488748 is registered in ClinicalTrials.gov with Sarah Lisanby as lead sponsor.

NCT NCT00488748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetic Seizure Therapy (MST) for the Treatment of Severe Mood Disorder
Lead sponsor
Sarah Lisanby
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2007
Completion date
August 31, 2012
Enrollment
75 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depression